Suppr超能文献

肠道微生物群和益生菌与慢性肝病。

Gut microbiota and probiotics in chronic liver diseases.

机构信息

Department of Clinical and Experimental Internistica "F. Magrassi and A. Lanzara", Gastroenterology Unit, Second University of Naples, Naples, Italy.

出版信息

Dig Liver Dis. 2011 Jun;43(6):431-8. doi: 10.1016/j.dld.2010.10.015. Epub 2010 Dec 16.

Abstract

There is a strong relationship between liver and gut: the portal system receives blood from the gut, and intestinal blood content activates liver functions. The liver, in turn, affects intestinal functions through bile secretion into the intestinal lumen. Alterations of intestinal microbiota seem to play an important role in induction and promotion of liver damage progression, in addition to direct injury resulting from different causal agents. Bacterial overgrowth, immune dysfunction, alteration of the luminal factors, and altered intestinal permeability are all involved in the pathogenesis of complications of liver cirrhosis, such as infections, hepatic encephalopathy, spontaneous bacterial peritonitis, and renal failure. Probiotics have been suggested as a useful integrative treatment of different types of chronic liver damage, for their ability to augment intestinal barrier function and prevent bacterial translocation. This review summarizes the main literature findings about the relationships between gut microbiota and chronic liver disease, both in the pathogenesis and in the treatment by probiotics of the liver damage.

摘要

肝脏和肠道之间存在着密切的关系

门静脉系统从肠道接收血液,而肠道血液中的内容物会激活肝脏功能。反过来,肝脏通过将胆汁分泌到肠腔中来影响肠道功能。肠道微生物群的改变似乎在诱导和促进肝损伤进展中起着重要作用,除了不同病原体直接造成的损伤。细菌过度生长、免疫功能障碍、管腔因子的改变以及肠道通透性的改变都与肝硬化并发症(如感染、肝性脑病、自发性细菌性腹膜炎和肾衰竭)的发病机制有关。益生菌被认为是一种有用的综合治疗方法,可以用于治疗不同类型的慢性肝损伤,因为它可以增强肠道屏障功能并防止细菌易位。这篇综述总结了关于肠道微生物群与慢性肝病之间关系的主要文献发现,包括在发病机制以及益生菌对肝损伤的治疗中的作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验